The QuantGen group, led by Drs. de los Campos and Vazquez has developed several methods and software packages for analysis of large-scale genomic data sets. The packages developed and maintained by the group include:
The QuantGen group, led by Drs. de los Campos and Vazquez, has developed and implemented methods for complex-trait prediction DNA information. This research has been funded by NIH grants R01GM0999992 and R01GM101219(PI de los Campos) and span from the development of parametric and semi-parametric methods, algorithms, and applications involving biobank-sized data. Selected publications: de los Campos et al. (2010) , Makowsky et al. (2011), de los Campos et al. (2013), de los Campos et al. 2015, Kim et al. (2017), Bellot et al. (2018), Lello et al. (2019)
Classical genomic models assumes that the effects of genes on disease risk are homogeneous across the subject of a population. However, genomic research has shown that sex and ethnic differences can modulate the effects of genes. de los Campos and Vazquez have developed whole-genome regression models that incorporate sex and ethnic differences as well as high-dimensional environmental information. Selected publications: Jarquin et al. (2015), Veturi et al. (2018), Funkhouser et al. (2020).
The QuantGen group contributes statistical and genetic expertise to the ORIGINs working group of the Enigma consortium. The prenatal and early postnatal period represents the foundational phase of human brain development This working group focuses on (1) Identifying genetic factors contributing to early brain development, (2) Developing predictive models for cognitive ability and emotional functioning using genetic variation, environmental risk factors, and neuroimaging phenotypes, and (3) Clarify how genetic risk for psychiatric disease manifests in infancy and early childhood.
Most of the genetic association studies of human diseases use case-control phenotypes (diseased vs. non-diseased). However, time-to-disease traits are more informative for the gene-disease association and are more suitable for building risk prediction models. We are developing robust and efficient statistical methods to detect genetic associations and predict disease risks with omics data for various types of survival outcomes and models. This project is led by Dr. Chenxi Li.
Substance use and polysubstance use have significant public health implications due to their widespread prevalence and associated mortality, morbidity, and economic costs. These issues have a profound impact not only on individuals who use substances but also on their families and broader communities. One of the limitations of previous studies on substance use disorder was assessed by self-reported, which may lead to inaccurate assessment and introduce bias. We have identified DNA methylation signatures as a robust biomarker for predicting different substances. Our results demonstrate that an objective measure of substance use is a more informative phenotype than self-reported data for revealing epigenetic mechanisms.